2nd Circ. Nixes RxUSA's Bid To Revive Antitrust Suit
Secondary drug-seller RxUSA Wholesale Inc. has failed to revive a $2.3 billion suit accusing drugmakers and major drug wholesalers of deliberately squeezing the company out of the market....To view the full article, register now.
Already a subscriber? Click here to view full article